Butterfly Network (BFLY) – Financial Prediction Report

BFLY – Trading Sideways Expected (5-day)

Butterfly Network, Inc. develops and commercializes handheld ultrasound devices. The company has a market cap of $2.33B, revenue of $97.61M (TTM), but remains unprofitable with negative net income and free cash flow.

BFLY surged 33% today on Midjourney Scanner collaboration news, but overbought RSI and price above analyst target cap upside potential.

Why This Matters

The stock is at a 52-week high with extreme overbought conditions. The catalyst is already priced in, and fundamental risks (negative margins, high beta) suggest limited further upside in the short term.

Key Insights

• Stock surged 33.19% to $7.61 (now $8.90) on Midjourney Scanner collaboration news, with volume 3x average.
• RSI at 84.58 indicates extreme overbought conditions, typically preceding a pullback or consolidation.
• Current price ($8.90) is 56% above the average analyst price target of $5.69, limiting institutional upside.
• Company has negative net income (-$77M TTM), negative free cash flow (-$16M), and high beta (2.20), increasing risk.
• Gross margin (46.85%) vs net margin (-78.95%) shows severe operational inefficiency, despite revenue growth.

Catalyst Analysis

The primary catalyst is the Midjourney Scanner collaboration announcement and today’s TD Cowen Emerging Growth Webinar. The stock already reacted with a 33%+ surge. Future iterations using more modules are a longer-term catalyst, but for the 5-day horizon, the immediate catalyst is already priced in. No additional 5%+ catalyst is expected within 5 days.

Signal Contradictions

Bullish news (100% positive) contradicts overbought RSI (84.58) and price above analyst target ($5.69). The stock has already moved significantly, reducing the probability of further near-term gains.

Margin & Efficiency Analysis

Gross margin (46.85%) is healthy, but net margin (-78.95%) is deeply negative. The gap of 125.8pp indicates high operating costs relative to revenue. Revenue growth (18.96%) is positive, but the company remains unprofitable, making it vulnerable to any slowdown.

Practical Implications

• Bull Case: The Midjourney collaboration could generate up to $74M over five years, providing a revenue stream. The product is innovative and could gain market share. Strong institutional ownership (55.71%) supports long-term value.
• Bear Case: The stock is overbought and above analyst targets. Negative cash flow and high burn rate raise sustainability concerns. The collaboration is still a prototype, with no guaranteed revenue. High beta (2.20) amplifies downside risk.
• Sideways Risk: High probability of consolidation or pullback due to overbought RSI and lack of additional near-term catalysts. The stock may trade between $7.50 and $9.00 in the next 5 days.
• Confidence: 5/10 – Confidence is 5/10. The news is very recent and bullish, but technicals (overbought RSI) and fundamental risks (negative margins, price above target) create contradictions. The 5% catalyst rule is satisfied but already realized. The target anchor rule caps confidence at 6/10. The sideways default rule does not apply (RSI >55), but the overbought condition favors sideways.

Prediction (5-day): sideways

---

Analysis Metadata:

• News Collection: 2026-06-18
• Analysis Date: 2026-06-18
• Target Date: 2026-06-23

References:

• https://www.investorideas.com/news/2026/biotech/06181-butterfly-network-bfly-soars-full-body-ultrasound-scanner.asp